Review
Open access
Sep 2026
Utility of exogenous melatonin in patients with breast cancer: A systematic review
Oral melatonin is well tolerated (no grade 3/4 toxicity) and reproducibly improves sleep quality and reproducibly improves sleep quality, with less certain signals for endocrine therapy-related symptoms, quality of life, and fatigue, justifying adequately powered, symptom-stratified trials.
Ji Yu, Jun-Fei Xu
· Cancer Plus · 0 citations